Genmab A/S Logo

Genmab A/S

Andre serviceaktiviteter

Om virksomheden
Ledige stillinger0

Employees are our most important resource, and we strive to attract and retain the most qualified people to fulfill our core purpose of improving patients’ lives.

We aspire to create a company environment which promotes both individual and team performance. We seek individuals with strong theoretical and practical qualifications and we aim to provide ongoing development of our employees.

Genmab’s compensation packages are competitive and we recognize employees’ performance through merit-based bonus and salary review programs.

We are committed to helping employees maintain a balance between work life and personal time by providing paid vacation, public holidays and other benefits such as disability, pension and health benefits. Benefits are managed locally on a site basis to comply with local legislation.

Our recognition and service awards programs celebrate employee successes and commitment to the company.

Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, DARZALEX® (daratumumab) for the treatment of certain multiple myeloma indications, and Arzerra® (ofatumumab) for the treatment of certain chronic lymphocytic leukemia indications. Daratumumab is in clinical development for additional multiple myeloma indications and solid tumors. A subcutaneous formulation of ofatumumab is in development for relapsing multiple sclerosis. Genmab also has a broad clinical and pre-clinical product pipeline. Genmab's technology base consists of validated and proprietary next generation antibody technologies - the DuoBody® platform for generation of bispecific antibodies, and the HexaBody® platform which creates effector function enhanced antibodies. The company intends to leverage these technologies to create opportunities for full or co-ownership of future products. Genmab has alliances with top tier pharmaceutical and biotechnology companies.

Op til 500Medarbejdere
1999Grundlæggelsesår

Kontaktoplysninger